Brickell Biotech posts quarterly revenue gain on strength of Botanix deal

BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) reported higher second-quarter revenue, largely on the strength of a recent asset-purchase agreement. Brickell recorded revenue of $4.3 million, compared with $200,000 in … Continued
Source: BizWest

Related Articles